Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant

Translational Oncology(2024)10.1016/j.tranon.2024.101907Source: DataRank Database

XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant is a research paper published in Translational Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.46)OA: goldTopics (22)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Steven Van Laere ORCID,Seayoung Lee,Michael A. Morse ORCID,Joseph Geradts ORCID,Luc Dirix

Live enrichment

PubMed:38412664 OpenAlex:https://openalex.org/W4392194078

FWO

Grant: 1189617N

US Department of Defense

Grant: W81XWH-17-1-0297

US Department of Defense

Grant: W81XWH-20-1-0153

National Cancer Institute

Grant: RO1CA264529-02

NCI NIH HHS

Grant: R01 CA264529

FWCI

1.46

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.tranon.2024.101907

publisherhttps://doi.org/10.1016/j.tranon.2024.101907

publisherhttps://api.elsevier.com/content/article/PII:S1936523324000329?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1936523324000329?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38412664

Fields of Study

Cell death mechanisms and regulationPhagocytosis and Immune RegulationImmune cells in cancer

Keywords

Infiltration (HVAC)Breast cancerXIAPMedicineInflammatory breast cancerCancer researchPathologyCancerInternal medicineBiologyApoptosisProgrammed cell deathCaspaseBirinapant, IAP-antagonistInflammatory breast cancer (IBC)PD-L1Tumor immune-microenvironment (TiME)Tumor necrosis factor - alpha (TNF-α)Tumor-associated macrophages (TAM)

Sustainable Development Goals

SDG 0: Good health and well-being